Quick summary
Sassafras albidum is a plant known for its aromatic properties and the presence of essential oils, including elemicin. It has been traditionally used and studied for various biological effects such as antimicrobial, antioxidant, and pesticidal activities. Research to date primarily includes chemical composition studies of its essential oils, potential insecticidal properties, and concerns over possible toxicity related to constituents like safrole and elemicin. Clinical human evidence regarding its efficacy or safety is limited or lacking.
What is it
Sassafras albidum is a deciduous tree native to North America, recognized for its distinctive aroma and use in traditional herbal preparations. The plant contains a variety of phytochemicals, notably essential oils found in its roots and bark, which contribute to its fragrance and bioactive properties.
Traditional uses
Traditionally, Sassafras has been used in folk medicine and as a flavoring agent. Its essential oils have been employed in remedies intended to support general health by leveraging its antimicrobial and aromatic qualities. It has also found historical use in insect repellents and pest control, although these applications are primarily based on traditional knowledge rather than rigorous clinical evidence.
Active compounds
- Elemicin: A major constituent of the essential oil with aromatic and biological activity.
- Safrole: Known for its distinctive scent but also linked to potential toxicity.
- Other alkenylbenzenes and aromatic compounds contributing to the plant’s chemical profile.
Potential benefits with evidence levels
- Antimicrobial and antioxidant properties (Preclinical evidence): Root-essential oils of Sassafras albidum have demonstrated antimicrobial and antioxidant effects in laboratory studies. However, human clinical trials are not available to confirm these effects.
- Potential pesticidal/insecticidal effects (Preclinical evidence): Essential oils from Sassafras species have shown insecticidal or repellent activities against fleas and other arthropods in veterinary and public health laboratory studies.
Side effects
There are concerns about potential hepatotoxicity associated with toxic compounds such as safrole and elemicin found in Sassafras. These constituents may undergo metabolic activation leading to cytotoxic effects, particularly in liver cells. Cases of herbal hepatotoxicity have been reported with some products containing related alkenylbenzene compounds. Adverse effects in humans specifically caused by Sassafras have not been systematically studied.
Drug interactions
No direct clinical evidence exists regarding drug interactions with Sassafras albidum. However, because elemicin is metabolized by cytochrome P450 enzymes including CYP1A1, CYP1A2, and CYP3A4, there is a theoretical risk of metabolic interactions with drugs processed by these pathways.
Who should avoid it
Use of Sassafras should be approached with caution or avoided in individuals with liver disease or risk factors due to potential hepatotoxicity. Additionally, because of insufficient safety data, its use is not recommended during pregnancy or breastfeeding.
Evidence limitations
The available evidence on Sassafras albidum primarily comes from preclinical, in vitro, chemical composition, and animal studies. No randomized controlled trials or clinical trials specifically investigating its effects or safety in humans have been identified. Additionally, lack of standardized preparations and quality control issues limit the applicability of current data. Safety concerns related to hepatotoxic phytochemicals warrant cautious use and further rigorous research.
References
- Campos DR, de Jesus ILR, Scott FB, Correia TR, Cid YP. Essential Oils and Bioproducts for Flea Control: A Critical Review. Europe PMC, 2025.
Reviewed essential oils including those from Sassafras species for insecticidal and repellent effects in flea control, indicating promising preclinical potential. - Lunz K, Stappen I. Back to the Roots-An Overview of the Chemical Composition and Bioactivity of Selected Root-Essential Oils. Europe PMC, 2021.
Reported the chemical composition and various bioactivities of root essential oils including Sassafras albidum, emphasizing antimicrobial, antioxidant, and pesticidal properties primarily from preclinical data. - Wang YK et al. Role of Metabolic Activation in Elemicin-Induced Cellular Toxicity. Europe PMC, 2019.
Demonstrated that elemicin, a constituent of Sassafras albidum, undergoes metabolic activation causing cytotoxicity in liver cell models, implicating cytochrome P450 enzymes. - Teschke R, Eickhoff A. Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps. Europe PMC, 2015.
Discussed herbal products including those containing safrole with potential hepatotoxic risks and emphasized the need for causality assessment and regulatory oversight. - Hassen G et al. Clinical Implications of Herbal Supplements in Conventional Medical Practice: A US Perspective. Europe PMC, 2022.
Overview of challenges and health risks related to herbal supplements, including possible toxicity, herb-drug interactions, and gaps in clinical evidence and practitioner knowledge.
Last reviewed
June 2024
Disclaimer: This page provides summary information about Sassafras (Sassafras albidum) based on current research and traditional use. It is not medical advice. Always consult a qualified healthcare professional before using herbal products, especially if you have underlying health conditions, are pregnant, nursing, or taking medications. The safety and efficacy of Sassafras have not been established in well-controlled clinical trials.